secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2024-04-17T23:59:59+00:00
Accession:  0001493152-24-015041
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 5.07, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa shareholders approve reverse stock split; board sets 1-for-10 ratio
---------------------------------------------------------------------------

- Shareholders approved reverse stock split at special meeting on April 17, 2024, with 2,058,182 votes for and 899,831 against.
- Board of directors subsequently authorized a 1-for-10 reverse stock split ratio.
- Reverse stock split effective at 4:01 p.m. ET on April 25, 2024; post-split trading begins April 26, 2024.
- New CUSIP number for common stock after reverse split: 98987D 300.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224015041/0001493152-24-015041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224015041/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer